Skip to main content

Table 3 Crude and adjusted associations between protein EpiScores and overall mortality in SATSA

From: Protein epigenetic scores and overall mortality in the longitudinal Swedish Adoption/Twin Study of Aging (SATSA)

 

Model 1- crude models (n = 374)

Model 2- adjusted models (n = 374)

Hazard ratio* (95% CI)

Harrell’s C-index

Hazard ratio* (95% CI)

Harrell’s C-index

Corrected p-value

Protein EpiScores considered risk factor

IGFBP4

1.25 (1.10–1.43)

0.61

1.23 (1.07–1.41)

0.65

0.03

MMP9

1.34 (1.17–1.52)

0.64

1.23 (1.06–1.42)

0.66

0.05

OSM

1.40 (1.23–1.59)

0.62

1.32 (1.14–1.51)

0.65

 < 0.01

PIGR

1.41 (1.23–1.63)

0.64

1.31 (1.10–1.56)

0.66

0.03

RARRES2

1.20 (1.06–1.35)

0.61

1.21 (1.07–1.38)

0.65

0.03

S100A12

1.24 (1.11–1.39)

0.60

1.21 (1.07–1.36)

0.64

0.03

STC1

1.43 (1.17–1.73)

0.61

1.48 (1.22–1.80)

0.65

 < 0.01

TGFA

1.40 (1.23–1.60)

0.64

1.31 (1.14–1.51)

0.66

 < 0.01

THBS2

1.22 (1.08–1.38)

0.61

1.18 (1.05–1.34)

0.66

0.05

Protein EpiScores considered protective factor

LY9

0.79 (0.69–0.92)

0.61

0.80 (0.70–0.93)

0.65

0.03

NCAM1

0.77 (0.67–0.87)

0.62

0.78 (0.67–0.90)

0.65

0.03

PREP

0.86 (0.76–0.98)

0.60

0.83 (0.73–0.94)

0.64

0.03

SEMA3E

0.74 (0.64–0.86)

0.62

0.79 (0.67–0.94)

0.65

0.05

WFIKKN2

0.76 (0.67–0.87)

0.62

0.80 (0.70–0.92)

0.65

0.03

  1. This table includes only proteins EpiScores with significant estimates in Cox proportional hazard models after FDR correction (corrected p-value). The Supplementary Table S3 shows the hazards ratios for all 109 protein EpiScores. SATSA: Swedish Adoption/Twin Study of Aging. Model 1 were adjusted for age (time scale) and sex. Model 2 were adjusted age (time scale), sex, education, smoking, body mass index, and occupation
  2. 95% CI, Confidence interval 95%; IGFBP4, Insulin-like growth factor-binding protein 4; LY9, Lymphocyte antigen 9; MMP9, Matrix metalloproteinase 9; NCAM1, Neural cell adhesion molecule 1; OSM, Oncostatin-M; PIGR, Polymeric immunoglobulin receptor; PREP, Prolyl endopeptidase; RARRES2, Retinoic acid receptor responder protein 2; S100A12, S100 calcium binding protein A12; SEMA3E, Semaphorin 3E; STC1, Stanniocalcin 1; TGFA, Transforming growth factor alpha; THBS2, Thrombospondin 2; WFIKKN2, WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2